CCL

Összesen 2 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM015809
035-os BibID:PMID:21443034 WOS:000288183200006
Első szerző:Da Costa, Rafael
Cím:Ferritin and prolactin levels in multiple sclerosis / Rafael Da Costa, Martine Szyper-Kravitz, Zoltan Szekanecz, Tünde Csépány, Katalin Dankó, Yinon Shapira, Gisele Zandman-Goddard, Hedi Orbach, Nancy Agmon-Levin, Yehuda Shoenfeld
Dátum:2011
ISSN:1565-1088 (Print)
Megjegyzések:Multiple sclerosis (MS) is a common demyelnating disorder of the central nervous system (CNS) and ethiopathogenesis has yet to be fully elucidated. The disease may present in several clinical forms that are closely associated with disease morbidity. In recent years various environmental and hormonal factors have been implicated in the pathogenesis of autoimmunity. OBJECTIVES: To evaluate ferritin and prolactin levels in MS patients and their correlation with clinical manifestations of the disease. METHODS: Serum samples from 150 multiple sclerosis patients were evaluated for demographic characteristics, clinical parameters as well as prolactin and ferritin levels utilizing the Liaison chemiluminescent immunoassays (DiaSorin, Italy). Sera from 100 matched healthy donors were used as controls. RESULTS: Hyperprolactinemia was documented in 10 of 150 MS patients (6.7%) and hyperferritinemia in 12 (8%), both of which were significantly more common in this group compared with healthy controls (P < 0.01 and P = 0.02 respectively). Among female MS patients, elevated prolactin levels were related to the secondary-progressive type of disease (P = 0.05), whereas hyperferritinemia was associated with male gender (P = 0.03) and with the relapsing-progressive type of the disease (P = 0.02). An inverse association was found between hyperferritinemia and the relapsing-remitting type of MS in male patients (P = 0.05) CONCLUSIONS: Our results suggest a plausible association between these biomarkers and certain clinical types and gender among MS patients. Further studies combining clinical data, CNS imaging and these markers are warranted.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Adult
Biological Markers/blood
Female
Ferritins/*blood
Humans
Hyperprolactinemia/epidemiology
Incidence
Iron Metabolism Disorders/epidemiology
Male
Middle Aged
Multiple Sclerosis/*blood/epidemiology
Prolactin/*blood
külföldön készült közlemény
Megjelenés:The Israel Medical Association journal : IMAJ. - 13 : 2 (2011), p. 91-95. -
További szerzők:Szyper-Kravitz, Martine Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus) Csépány Tünde (1956-) (neurológus, pszichiáter) Dankó Katalin (1952-2021) (belgyógyász, allergológus és klinikai immunológus) Shapira, Yinon Zandman-Goddard, Gisele Orbach, Hedi Agmon-Levin, Nancy Shoenfeld, Yehuda
Internet cím:elektronikus változat
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM015831
Első szerző:Kivity, Shaye
Cím:Vitamin D and autoimmune thyroid diseases / Kivity, S., Agmon-Levin, N., Zisappl, M., Shapira, Y., Nagy, E. V., Danko, K., Szekanecz, Z., Langevitz, P., Shoenfeld, Y.
Dátum:2011
ISSN:2042-0226 (Electronic)
Megjegyzések:The role of vitamin D as an immune modulator has been emphasized in recent years, and low levels of the hormone were observed in several autoimmune diseases including multiple sclerosis and systemic lupus erythematosus. Vitamin D mediates its effect though binding to vitamin D receptor (VDR), and activation of VDR-responsive genes. While VDR gene polymorphism was found to associate with autoimmune thyroid diseases (AITDs), few studies examined levels of vitamin D in these patients and those that did yielded conflicting results. We therefore undertook to evaluate the levels of vitamin D in patients with AITDs compared to patients with non-AITDs and healthy controls. Serum vitamin D (25-OH) levels were measured in 50 patients with AITDs, 42 patients with non-AITDs and 98 healthy subjects, utilizing the LIAISON chemiluminescence immunoassay (DiaSorin, Saluggia, Italy). Vitamin D deficiency was designated at levels lower than 10 ng/ml. Antithyroid antibodies, thyroid functions and demographic parameters were evaluated in all patients. The prevalence of vitamin D deficiency was significantly higher in patients with AITDs compared with healthy individuals (72% versus 30.6%; P<0.001), as well as in patients with Hashimoto's thyroiditis compared to patients with non-AITDs (79% versus 52%; P<0.05). Vitamin D deficiency also correlated to the presence of antithyroid antibodies (P=0.01) and abnormal thyroid function tests (P=0.059). Significantly low levels of vitamin D were documented in patients with AITDs that were related to the presence of anti thyroid antibodies and abnormal thyroid function tests, suggesting the involvement of vitamin D in the pathogenesis of AITDs and the advisability of supplementation.Cellular & Molecular Immunology advance online publication, 31 January 2011; doi:10.1038/cmi.2010.73.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Cellular and Molecular Immunology. - 8 : 3 (2011), p. 243-247. -
További szerzők:Agmon-Levin, Nancy Zisappl, Michael Shapira, Yinon Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Dankó Katalin (1952-2021) (belgyógyász, allergológus és klinikai immunológus) Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus) Langevitz, Pnina Shoenfeld, Yehuda
Internet cím:DOI
elektronikus változat
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1